Enduring Questions

Back to:New Funds Possible for Embryo Research The ethical reasoning of the panel advising the National Institutes of Health on human embryo research was clearly expressed by its policy cochairwoman at a news conference at which the group's report was released in September. "The basic finding of the panel is that it is acceptable public policy to fund research on the human embryo, subject to stringent guidelines," said Pa

Written byFranklin Hoke
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The ethical reasoning of the panel advising the National Institutes of Health on human embryo research was clearly expressed by its policy cochairwoman at a news conference at which the group's report was released in September.

"The basic finding of the panel is that it is acceptable public policy to fund research on the human embryo, subject to stringent guidelines," said Patricia A. King, who is also a professor of law at Georgetown University Law Center, Washington, D.C. "There were three principles that guided us in our determination. First, that the promise of benefit from doing research on the human embryo was significant and carried great potential for couples and for families and for individuals. Two, that the preimplantation embryo warrants serious moral consideration but does not have the same moral status as infants and children. And three, that federal funding and regulation will help bring about consistent ethical and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies